The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite by Sugidachi A, Ogawa T, Kurihara A, Hagihara K, Jakubowski J A, Hashimoto M, Niitsu Y, Asai F in Journal of thrombosis and haemostasis : JTH (2007).

[PMID: 17456192] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.